NJNusrat Jahan

Nusrat Jahan

*This is an algorithmically generated author record based on publicly available information.

Nusrat Jahan has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Neuropharmacological Evaluation of Amaranthus blitum Leaf Extract in Mice: Sedative, Anxiolytic-like, Antidepressant-like and Cognition-Related Behavioural Effects

    by Taiba Chowdhury, Farjana Akter Nipa, Swarupa Kundu, Mycal Dutta, Nazratun Noor Maria, Nusrat Jahan

    Objectives: Amaranthus blitum L. (Amaranthaceae) is a widely consumed leafy vegetables with diverse pharmacological activities; however, its central nervous system effects remain under-explored. The study aimed to evaluate the neuropharmacological potential of the methanolic extract of A. blitum leaves (MEAB) using validated in vivo models in mice. Methods: Mice were orally administered MEAB (100, 200, and 400 mg/kg) and subjected to a series of behavioral tests, including open field, hole-cross, elevated plus maze (EPM), light–dark box, hole-board, forced swimming test (FST), tail suspension test (TST), social interaction, and Y-maze tests. Results: MEAB produced significant, dose-dependent neuropharmacological effects. Locomotor activity was markedly reduced in the open field test ( p p p <0.001), indicating improved cognitive function. Conclusion: The findings suggest that MEAB possesses significant CNS-modulating effects, possibly mediated through GABAergic and monoaminergic pathways. Further studies are required to elucidate the precise molecular mechanisms.

  • Experimental and computational evidence for the antihyperlipidemic potential of Tetrastigma angustifolia with possible involvement of HMG-CoA reductase

    by Ummah Tasnim Nisat, Tazim Hasan Fahim, Nazratun Noor Maria, Namira Jannat, Shanjina Meherin, Bilkis Akter, Nusrat Jahan, Mohammad Nazmul Islam, Aftab A. Sorwar, Md. Zia Uddin

  • Open Access

    Protective Effects of Mussaenda pubescens Leaf Extracts Against Oxidative Stress and Dyslipidemia

    by Md. Tazim Hasan Fahim, Ummah Tasnim Nisat, Nazratun Noor Maria, Nusrat Jahan, Sajeda Akter, Aftab A. Sorwar

    Objective: Mussaenda pubescens (Rubiaceae) is a medicinal plant, traditionally utilized for gastrointestinal, febrile, and reproductive ailments. This study was aimed at analyzing the antioxidant capacity and antihyperlipidemic efficacy of the methanolic extract of M. pubescens in a high‐cholesterol diet‐induced hyperlipidemic mouse model. Methods: Twenty‐five Swiss albino mice were randomly subdivided into five groups of five mice each: normal control, disease control, atorvastatin (20 mg/kg), 200 mg/kg of the extract, and 400 mg/kg of the extract. Hyperlipidemia was achieved by feeding a high‐fat diet for 28 days before the oral treatment was given for 12 consecutive days. The serum lipid profile and DPPH radical scavenging activity were then analyzed. Results: The extract improved the lipid abnormalities when compared with untreated hyperlipidemic mice ( p < 0.05). At 200 mg/kg, LDL‐C decreased to 11.25 ± 1.05 mg/dL, whereas the 400 mg/kg dose reduced TG and VLDL‐C to 140.50 ± 6.50 and 28.10 ± 1.30 mg/dL, respectively. Atorvastatin demonstrated greater lipid normalization. The antioxidant activity was also shown by the extract with a DPPH assay, with an IC 50 value of 235.64 μ g/mL. Conclusion: The methanolic extract of M. pubescens exhibits potent antihyperlipidemic and antioxidant activities, validating its potential as a promising phytotherapeutic candidate for the management of hyperlipidemia and oxidative stress–associated metabolic disorders. Further in‐depth phytochemical profiling and mechanistic studies are required for better evaluation of this extract.

  • Open Access

    Antianemic Potential of Artocarpus chaplasha Seeds in Phenyl Hydrazine–Induced Hemolytic Anemia: Evidence From Swiss Albino Mice and Molecular Docking Studies

    by Nazratun Noor Maria, Ummah Tasnim Nisat, Nusrat Jahan, Zobayed Islam, Adnan Shahriar Chowdhury, Mehnaz Sarwar, Sajeda Akter

    Background and Aim: Anemia affects billions, primarily young women and men. Taking steroids and immunosuppressants might cause side effects. So recent studies are focusing on natural hematinic agents to cure anemia. This study examined Artocarpus chaplasha seeds against phenyl hydrazine–induced hemolytic anemia in Swiss albino mice. Methods: To induce anemia, mice administered 60 mg/kg phenyl hydrazine intraperitoneally for 2 days. On Day 3, decreased RBC, hemoglobin, and hematocrit levels revealed anemia. Mice were orally treated with A. chaplasha seed methanol extract. Vitamin B 12 was the reference standard. Post 200 and 400 mg/kg test extract administration, blood was taken for hematological analysis on Day 15. All in vivo results were analyzed and supported through in silico approach. Results: Compared to positive control group, A. chaplasha seeds doses of 200 and 400 mg/kg significantly ( ∗∗ p < 0.01) increased RBC levels. Hemoglobin levels considerably increased with 200 mg/kg ( ∗ p < 0.05) and 400 mg/kg ( ∗∗ p < 0.01). The 200 and 400 mg/kg doses significantly elevated hematocrit (PCV) levels ( ∗ p < 0.05 and ∗∗∗ p < 0.001). Furthermore, in silico molecular docking studies showed significant binding affinity of the compounds against the receptor protein (PDB ID: 2HHB). With −7.2 kcal/mol, neophytadiene bound strongly. Conclusion: The in vivo activity demonstrate increase in the RBC level, and docking score shows comparability to the positive control, folinic acid with a score of −6.9 kcal/mol. Thus, the A. chaplasha seed may be a promising natural anemic treatment.

  • Open Access

    Antipyretic, Analgesic, and Anti‐Inflammatory Activities of Artocarpus chaplasha Seeds Validated by In Silico Analysis

    by Nazratun Noor Maria, Farjana Nawrin, Nusrat Jahan, Saurav Singha, Namira Jannat, Tanveer Ahsan, Zia Uddin

    Background: The rare native Bangladeshi medicinal plant Artocarpus chaplasha has long been utilized to treat different illnesses. While its bark, leaves, and roots have folk uses, the seeds remain underexplored. The research aimed to evaluate the antipyretic, analgesic, and anti‐inflammatory properties of the methanolic seed extract to substantiate traditional medicine claims and identify therapeutic potential. Methods: Mature seeds were collected, shade‐dried, powdered, and soaked in methanol. Female Swiss albino mice were utilized for in vivo assays. Antipyretic activity was assessed via pyrexia induced by brewer’s yeast, analgesic potential through acetic acid–induced writhing and paw licking tests induced by formalin, and anti‐inflammatory activity via formalin and carrageenan‐induced paw edema models. Standard drugs (paracetamol, diclofenac, morphine, and indomethacin) served as controls. Molecular docking was performed against analgesic (PDB ID: 5DU1), anti‐inflammatory (PDB ID: 5O0X), and antipyretic activity (PDB ID: 5F15) for 2 selected phytoconstituents, tetra decanoic acid, 10,13‐dimethyl‐, methyl ester, and neophytadiene. Results: The extract significantly ( p < 0.005–0.001) reduced yeast‐induced hyperthermia in a dose‐dependent manner, comparable to paracetamol. Analgesic assessment showed marked writhing inhibition (56.52%) and notable decrease in paw licking duration in both neurogenic and inflammatory phases, suggesting central and peripheral antinociceptive actions. Anti‐inflammatory evaluation revealed substantial inhibition of paw edema in both models, with stronger effects at higher doses. Conclusion: A. chaplasha methanolic seed extract possesses potent antipyretic, analgesic, and anti‐inflammatory activities, validating its traditional use and indicating the presence of promising bioactive compounds. Further phytochemical profiling and mechanistic studies are needed for potential plant‐derived therapeutics.